drugset / Trial / NCT00954122
Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to determine whether treatment with quetiapine XR (Seroquel XR) tablets for 3 weeks will improve their agitation when they have acute psychosis.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-03
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 400 mg | Oral |
| Subject | Quetiapine | Small molecule | 800 mg | Oral |